A bunch of CRISPR links!
Here are some of the most fascinating CRISPR articles I came across this week:
Drug Target Review reports on a novel vaccine being developed with CRISPR tech to protect against Leishmania.
The Genetic Literacy Project explains how CRISPR helped researchers uncover a novel pathway in an antibiotic called malonomycin.
A CRISPR screen helps to identify host factors involved in COVID-19, News Medical reports.
The Motley Fool tells you which CRISPR stocks are hot right now.
Hemophilia News Today report how gene editing with CRISPR may be superior to traditional gene therapy specifically when treating hemophilia.